BCL2 and neoplasm: In analogy to BCL2 knockout, venetoclax alone did not alter tumor growth, whereas the combination of venetoclax plus chemotherapy clearly decreased tumor load, indicating the potential of venetoclax to overcome treatment resistance to polychemotherapy (Fig. 4H, I and S9C, D).